SC to govt: Why can't SMA med be as cheap in India as in Pakistan, China?

The Supreme Court of India seeks responses from the Centre and Roche on making the spinal muscular atrophy treatment drug Risdiplam affordable in India. The move comes after it was reported that the drug is much cheaper in Pakistan and China due to government interventions.
|
|||||||||
You Might Like💡 newsR Knowledge: Other News Mentions
|
![]()
“I Could Call Bukele, But Won’t”: Trump Doubles Down On Abrego García's Deportation To El Salvador
Credit: Oneindia Duration: 03:25Published
|
![]()
China Fumes as U.S Ally Australia Sends Warship to South China Sea| South China Sea Tensions Explode
Credit: Oneindia Duration: 03:38Published
|
![]()
Trump Brags About Tariff Success in China: 'Cargo Ships Turning Back', Says Tariffs Hammering China
Credit: Oneindia Duration: 02:01Published
|
Related news from verified sources
Centre Accelerates PM E-Drive Scheme With More EV Charging StationsThe Centre has received inputs from as many as 14 states for its stepped-up campaign under the PM E-Drive scheme.Zee News Also reported by •IndiaTimes |
Setback for Tamil Nadu as Centre declines consent for anti-NEET billTamil Nadu Chief Minister M.K. Stalin announced that the Centre has rejected the state's Assembly resolution seeking NEET exemption. Despite submitting all...IndiaTimes |
Centre downgrades security cover for ex-PM Manmohan Singh's wifeThe Centre has downgraded Gursharan Kaur's security cover from Z-plus to Z, following a review of her threat perception. This change comes after the passing of...IndiaTimes |